Selling by month
Oct 2025 to Oct 2026. Each sale is counted once: under a disclosed plan, else to cover taxes, else no plan disclosed.
To cover taxesNo plan disclosedOne dollar scale for every month; the tallest bar is labeled
Pattern
What the filings show, past 12 months. Nothing here rates or predicts.
- Sold in 8 of the 13 calendar months from Oct 2025 to Oct 2026: Nov 2025, Feb 2026, Apr 2026, May 2026, Jun 2026, Jul 2026, Aug 2026 and Oct 2026.
- Largest single sale: $563K (14,748 shares) of Immunovant, Inc. on Jun 26, 2026. Filing
- No sale on record before this period.
Roles from filings
Every company we track where this person has filed, newest filing first.
| Company | Title | First filing | Latest filing |
|---|---|---|---|
| Immunovant, Inc. (IMVT) | Chief Operating Officer | Nov 20, 2024 | Oct 9, 2026 |
Recent filings
The last 5 days with transactions, newest first, one line per trade date. Each number links to an SEC filing.
- Oct 7, 2026, Immunovant, Inc.: sold 2,241 shares for $72K, to cover taxes. 1 filing: 1
- Aug 20, 2026, Immunovant, Inc.: sold 3,056 shares for $135K, to cover taxes. 1 filing: 1
- Jul 8, 2026, Immunovant, Inc.: sold 2,036 shares for $81K, to cover taxes. 1 filing: 1
- Jun 26, 2026, Immunovant, Inc.: sold 17,714 shares for $679K, no plan disclosed. 1 filing: 1
- May 20, 2026, Immunovant, Inc.: sold 3,115 shares for $101K, to cover taxes. 1 filing: 1
This page shows only what this person reported on SEC ownership filings. See the methodology. Spotted something wrong? Report an error.